Answers are grounded in this paper and cite their sources.
In the field of medicinal chemistry, the versatility of the thiosemicarbazone scaffold makes it a promising platform for the development of next-generation pharmaceuticals. In this paper the thiosemicarbazone scaffold was explored to obtain novel series of derivatives: a) thiosemicarbazones 15 – 31, and 33 containing a linear thiosemicarbazone scaffold, b) 34 – 38 and 44 – 64 containing pyrazoline ring, and c) 39 – 43 containing the dihydropyrimidine cycle. Among these, compounds 21 , 23 , 26 , 33 – 35 , 37 , 38 , 44 , 57 , 61 , and 62 demonstrated no significant cytotoxic effects on HDFa cells at concentrations up to 500 μg/mL. Importantly, compounds 21 , 23 , 26 , 33 , 34 , 35 , and 37 exhibited significant protective effects against neurotoxicity induced by beta-amyloid peptide (1-42) in differentiated SHSY-5Y cell cultures. Enzymatic assays targeting BACE1 and AChE revealed modest inhibitory activity in compounds 21 , 23 , and 34 , 37 , respectively. The identification of compounds with inhibitory effects and neuroprotective activity against beta-amyloid peptide (1-42) offers a platform for further optimization and refinement of these compounds to enhance their potency and selectivity. • Thiosemicarbazones derivatives: Versatile scaffold explored for Alzheimer's drug development. • Potential Alzheimer's treatments via BACE1 and AChE inhibition and neuroprotection. • Thiosemicarbazones derivatives demonstrated protection against beta-amyloid-induced neurotoxicity in SHSY-5Y cells.
No takes yet. Share an insight, caveat, or question.
Katsogiannou et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: